Geode Capital Management
NDRM

Geode Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Geode Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,827
Closed -$693K – 4134
2017
Q3 		$693K Buy
17,827
+234
+1% +$8.61K ﹤0.01% 3251
2017
Q2 		$526K Buy
17,593
+3,247
+23% +$84.1K ﹤0.01% 3339
2017
Q1 		$380K Buy
14,346
+4,541
+46% +$112K ﹤0.01% 3417
2016
Q4 		$217K Buy
+9,805
New +$183K ﹤0.01% 3591

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Geode Capital Management's NDRM Position: Q4 2017 in Review

Geode Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 17,827 shares — an estimated $693K sold.

Geode Capital Management first reported a position in NDRM in Q4 2016 and held it in 4 quarters. The position peaked at $693K in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Geode Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Geode Capital Management sold 17,827 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $693K.
  • Geode Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2016 and held it in 4 quarters.
  • Geode Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $693K in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.